HRP20221075T1 - Spojevi za sprječavanje i liječenje kožnih ili sluzničnih oboljenja koji imaju upalnu komponentu - Google Patents
Spojevi za sprječavanje i liječenje kožnih ili sluzničnih oboljenja koji imaju upalnu komponentu Download PDFInfo
- Publication number
- HRP20221075T1 HRP20221075T1 HRP20221075TT HRP20221075T HRP20221075T1 HR P20221075 T1 HRP20221075 T1 HR P20221075T1 HR P20221075T T HRP20221075T T HR P20221075TT HR P20221075 T HRP20221075 T HR P20221075T HR P20221075 T1 HRP20221075 T1 HR P20221075T1
- Authority
- HR
- Croatia
- Prior art keywords
- skin
- together form
- methyl
- sandal
- pentanol
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims 3
- 230000002757 inflammatory effect Effects 0.000 title 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 claims 6
- 239000002537 cosmetic Substances 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 3
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- 208000035985 Body Odor Diseases 0.000 claims 1
- 206010055000 Bromhidrosis Diseases 0.000 claims 1
- 102000030805 Dermcidin Human genes 0.000 claims 1
- 108010034929 Dermcidin Proteins 0.000 claims 1
- 208000010201 Exanthema Diseases 0.000 claims 1
- 206010016936 Folliculitis Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 241001303601 Rosacea Species 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 201000005884 exanthem Diseases 0.000 claims 1
- 238000011010 flushing procedure Methods 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 210000004400 mucous membrane Anatomy 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 206010037844 rash Diseases 0.000 claims 1
- 201000004700 rosacea Diseases 0.000 claims 1
- 210000004761 scalp Anatomy 0.000 claims 1
- 210000003491 skin Anatomy 0.000 claims 1
- 231100000046 skin rash Toxicity 0.000 claims 1
- 230000000638 stimulation Effects 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Claims (5)
1. Sandal pentanol za uporabu u lokalnom liječenju bolesti kože, vlasišta ili sluznice promicanjem aktivnosti stimulacije imuniteta posredovane dermcidinom naznačen time što je bolest odabrana iz skupine koju čine psorijaza, rosacea, folikulitis, kožni osip.
2. Pripravak koji sadrži fiziološki prihvatljiv nosač i sandal pentanol za uporabu prema zahtjevu 1.
3. Kozmetička uporaba sandal pentanola kao kozmetičkog tretmana za njegu kože naznačen time što je barem jedno područje kože zahvaćeno crvenilom, rumenilom kože, crvenilom kože.
4. Kozmetička uporaba spoja formule (I)
[image]
pri čemu:
R1 i R2 zajedno tvore dvostruku vezu, ili R1 i R2 zajedno tvore ciklopropilnu skupinu;
R3, R4 su isti ili različiti i neovisno odabrani između vodika, metila,
ili R3 i R4 zajedno tvore dvostruku vezu;
R5, R6 su isti ili različiti i neovisno odabrani između vodika, metila;
ili R5 i R6 zajedno tvore dvostruku vezu, ili R5 i R6 zajedno tvore ciklopropilnu skupinu;
R7 = metil, ili etil;
R8 = vodik, ili metil,
za prevenciju ili liječenje bromhidroze.
5. Kozmetička uporaba pripravka koji sadrži fiziološki prihvatljiv nosač i spoj formule (I) prema zahtjevu 4.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102018000005585A IT201800005585A1 (it) | 2018-05-22 | 2018-05-22 | Composti per prevenire e trattare affezioni della pelle o della mucosa con componente infiammatoria |
PCT/EP2019/063143 WO2019224211A1 (en) | 2018-05-22 | 2019-05-21 | Compounds for preventing and treating skin or mucosal affections having an inflammatory component |
EP19731151.7A EP3796897B1 (en) | 2018-05-22 | 2019-05-21 | Compounds for preventing and treating skin or mucosal affections having an inflammatory component |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20221075T1 true HRP20221075T1 (hr) | 2022-11-11 |
Family
ID=63014978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20221075TT HRP20221075T1 (hr) | 2018-05-22 | 2019-05-21 | Spojevi za sprječavanje i liječenje kožnih ili sluzničnih oboljenja koji imaju upalnu komponentu |
Country Status (15)
Country | Link |
---|---|
US (1) | US11759432B2 (hr) |
EP (1) | EP3796897B1 (hr) |
JP (1) | JP2021525253A (hr) |
CA (1) | CA3100564A1 (hr) |
DK (1) | DK3796897T3 (hr) |
ES (1) | ES2926378T3 (hr) |
HR (1) | HRP20221075T1 (hr) |
HU (1) | HUE059806T2 (hr) |
IT (1) | IT201800005585A1 (hr) |
LT (1) | LT3796897T (hr) |
PL (1) | PL3796897T3 (hr) |
PT (1) | PT3796897T (hr) |
RS (1) | RS63527B1 (hr) |
SI (1) | SI3796897T1 (hr) |
WO (1) | WO2019224211A1 (hr) |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07109481A (ja) * | 1993-10-12 | 1995-04-25 | Pola Chem Ind Inc | 香料組成物、及びそれを含有する化粧料並びに芳香剤 |
US5759556A (en) * | 1996-09-27 | 1998-06-02 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Skin care compositions containing certain cyclic aliphatic unsaturated compounds and retinol or retinyl ester |
DE69920567T2 (de) * | 1998-03-31 | 2005-10-06 | Shiseido Co. Ltd. | Methode zur Verhütung des Körpergeruchs von alten Leute |
GB9918022D0 (en) * | 1999-07-30 | 1999-09-29 | Unilever Plc | Skin care composition |
JP2001348308A (ja) * | 2000-03-13 | 2001-12-18 | Lion Corp | 菌代謝阻害剤 |
JP2003502482A (ja) * | 2000-05-31 | 2003-01-21 | 株式会社資生堂 | 香気成分の捕集方法及びこれによる香気成分を含む香料組成物並びに化粧品 |
EP1181866A1 (en) * | 2000-08-14 | 2002-02-27 | Givaudan SA | Antibacterial composition comprising Sandela |
EP1184030A1 (en) * | 2000-08-14 | 2002-03-06 | Givaudan SA | Antibacterial composition comprising trimethylnorbornanylcyclohexanol derivatives |
JP2004359602A (ja) * | 2003-06-04 | 2004-12-24 | Shiseido Co Ltd | 皮膚外用剤 |
ES2324192B1 (es) | 2008-01-30 | 2010-06-17 | PUIG BEAUTY & FASHION GROUP, S.L. | Derivados peptidicos utiles en el tratamiento, cuidado o limpieza de la piel, mucosa, cuero cabelludo o uñas. |
JP5615527B2 (ja) * | 2009-11-05 | 2014-10-29 | 日本メナード化粧品株式会社 | オキシトシン産生促進剤 |
CN102985091B (zh) * | 2010-03-03 | 2016-11-23 | 新科蒂斯公司 | 使用抗微生物肽螯合化合物治疗皮肤疾病和异常的组合物和方法 |
EP2957283B1 (de) * | 2014-06-19 | 2022-12-21 | Symrise AG | Verfahren zur Identifizierung von Medikamenten zur Beschleunigung der Wundheilung |
ITUA20163604A1 (it) * | 2016-05-19 | 2017-11-19 | Giuliani Spa | Composti atti a promuovere la crescita dei capelli nell'uomo e/o a fermarne o ritardarne la caduta, e composizioni per tali usi |
-
2018
- 2018-05-22 IT IT102018000005585A patent/IT201800005585A1/it unknown
-
2019
- 2019-05-21 SI SI201930311T patent/SI3796897T1/sl unknown
- 2019-05-21 CA CA3100564A patent/CA3100564A1/en active Pending
- 2019-05-21 RS RS20220781A patent/RS63527B1/sr unknown
- 2019-05-21 PT PT197311517T patent/PT3796897T/pt unknown
- 2019-05-21 LT LTEPPCT/EP2019/063143T patent/LT3796897T/lt unknown
- 2019-05-21 HR HRP20221075TT patent/HRP20221075T1/hr unknown
- 2019-05-21 PL PL19731151.7T patent/PL3796897T3/pl unknown
- 2019-05-21 ES ES19731151T patent/ES2926378T3/es active Active
- 2019-05-21 HU HUE19731151A patent/HUE059806T2/hu unknown
- 2019-05-21 JP JP2020565400A patent/JP2021525253A/ja active Pending
- 2019-05-21 DK DK19731151.7T patent/DK3796897T3/da active
- 2019-05-21 EP EP19731151.7A patent/EP3796897B1/en active Active
- 2019-05-21 US US17/057,814 patent/US11759432B2/en active Active
- 2019-05-21 WO PCT/EP2019/063143 patent/WO2019224211A1/en active Search and Examination
Also Published As
Publication number | Publication date |
---|---|
ES2926378T3 (es) | 2022-10-25 |
JP2021525253A (ja) | 2021-09-24 |
EP3796897A1 (en) | 2021-03-31 |
CA3100564A1 (en) | 2019-11-28 |
PT3796897T (pt) | 2022-09-02 |
HUE059806T2 (hu) | 2022-12-28 |
RS63527B1 (sr) | 2022-09-30 |
LT3796897T (lt) | 2022-09-26 |
IT201800005585A1 (it) | 2019-11-22 |
US20220071921A1 (en) | 2022-03-10 |
WO2019224211A1 (en) | 2019-11-28 |
PL3796897T3 (pl) | 2022-11-21 |
US11759432B2 (en) | 2023-09-19 |
EP3796897B1 (en) | 2022-06-22 |
SI3796897T1 (sl) | 2022-11-30 |
DK3796897T3 (da) | 2022-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112022012641A2 (pt) | Compostos tricíclicos substituídos | |
JOP20190257A1 (ar) | مركبات أريل غير متجانسة ثنائية الحلقة مندمجة 6-6 واستخدامها كمثبطات lats | |
MX2017000612A (es) | Inhibidores de tirosina quinasa del bazo (syk). | |
MX2016004030A (es) | Inhibidores sustituidos de nicotinamida de btk y su preparacion y uso en el tratamiento del cancer, inflamacion y enfermedad autoinmune. | |
TR201816176T4 (tr) | Histon deasetilaz 6 inhibitörleri olarak yeni bileşikler ve bunu içeren farmasötik bileşimler. | |
MA38380A1 (fr) | Inhibiteurs quinazoline de l'activation des formes mutantes du récepteur de croissance épidermique (egfr) | |
MY167423A (en) | Quinoline carboxamide and quinoline carbonitrile derivatives as mglur2-negative allosteric modulators,compositions,and their use | |
HRP20210223T1 (hr) | Spojevi za promicanje rasta kose i/ili sprječavanje ili odgađanje gubitka kose kod ljudi i pripravci za takve uporabe | |
EA201592250A1 (ru) | Пиразолопирролидиновые производные и их применение в лечение заболеваний | |
PH12020550499A1 (en) | Substituted pyrrolopyrimidine jak inhibitors and methods of making and using the same | |
EA201490647A1 (ru) | Производные бензотиазол-6-илуксусной кислоты и их применение для лечения вич-инфекции | |
EA201592256A1 (ru) | Производные имидазопирролидинона и их применение при лечении заболеваний | |
EA201291310A1 (ru) | Композиция ингибитора jak для местного применения | |
BR112012033117A2 (pt) | pirazolo[1,5-a]pirimidinas como agentes antivirais | |
EA201101479A1 (ru) | Новые p2x7r антагонисты и их применение | |
EA201001522A1 (ru) | Новые p2x7r антагонисты и их применение | |
PH12020500543A1 (en) | Nonracemic mixtures and uses thereof | |
EA201992607A1 (ru) | Твердые формы берберина урсодезоксихолата, их композиции и способы | |
EA201591541A1 (ru) | Ингибиторы бета-секретазы 1 (bace 1) | |
MX2019013561A (es) | Compuestos de pirrolopiridina-anilina para el tratamiento de trastornos dermicos. | |
MX356343B (es) | Compuestos que inhiben la exocitosis neuronal (ii). | |
EA201492097A1 (ru) | 5-амино[1,4]тиазины в качестве ингибиторов бета-секретазы 1 | |
EA201990818A1 (ru) | ПРОИЗВОДНЫЕ ХРОМАНА, ИЗОХРОМАНА И ДИГИДРОИЗОБЕНЗОФУРАНА В КАЧЕСТВЕ НЕГАТИВНЫХ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ РЕЦЕПТОРОВ mGluR2, ИХ КОМПОЗИЦИИ И ПРИМЕНЕНИЕ | |
EA201992152A1 (ru) | Химические соединения | |
DE60106026D1 (de) | 2-arachidonylglycerol, ein hemmer des tumor nekrose faktors -alfa und neuroprotektor des gehirns bei geschlossenen kopfverletzungen |